This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, X. Articles by Godwin, A. K. Search for Related Content PubMed PubMed Citation Articles by Chen, X. Articles by Godwin, A. K.

BRCC36 Is Essential for Ionizing Radiation–Induced BRCA1 Phosphorylation and Nuclear Foci Formation

Departments of ¹ Medical Oncology and ² Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania

Requests for reprints: Andrew K. Godwin, Department of Medical Oncology, 333 Cottman Avenue, Philadelphia, PA 19111. Phone: 215-728-2205; Fax: 215-728-2741; E-mail: Andrew.Godwin{at}fccc.edu.

We have previously reported the identification and characterization of a novel BRCA1/2 interacting protein complex, BRCC (BRCA1/2-containing complex). BRCC36, one of the proteins in BRCC, directly interacts with BRCA1, and regulates the ubiquitin E3 ligase activity of BRCC. Importantly, BRCC36 is aberrantly expressed in the vast majority of breast tumors, indicating a potential role in the pathogenesis of this disease. To further elucidate the functional consequence of abnormal BRCC36 expression in breast cancer, we have done in vivo silencing studies using small interfering RNAs targeting BRCC36 in breast cancer cell lines, i.e., MCF-7, ZR-75-1, and T47D. Knock-down of BRCC36 alone does not affect cell growth, but when combined with ionizing radiation (IR) exposure, it leads to an increase in the percentage of cells undergoing apoptosis when compared with the small interfering RNA control group in breast cancer cells. Immunoblot analysis shows that inhibition of BRCC36 has no effect on the activation of ATM, expression of p21 and p53, or BRCA1-BARD1 interaction following IR exposure. Importantly, BRCC36 depletion disrupts IR-induced phosphorylation of BRCA1. Immunofluorescent staining of BRCA1 and -H2AX indicates that BRCC36 depletion prevents the formation of BRCA1 nuclear foci in response to DNA damage in breast cancer cells. These results show that down-regulation of BRCC36 expression impairs the DNA repair pathway activated in response to IR by inhibiting BRCA1 activation, thereby sensitizing breast cancer cells to IR-induced apoptosis. (Cancer Res 2006; 66(10): 5039-46)

This article has been cited by other articles:

				L. Rink, Y. Skorobogatko, A. V. Kossenkov, M. G. Belinsky, T. Pajak, M. C. Heinrich, C. D. Blanke, M. von Mehren, M. F. Ochs, B. Eisenberg, et al. Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor Mol. Cancer Ther., August 1, 2009; 8(8): 2172 - 2182. [Abstract] [Full Text] [PDF]

				B. Wang, K. Hurov, K. Hofmann, and S. J. Elledge NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control Genes & Dev., March 15, 2009; 23(6): 729 - 739. [Abstract] [Full Text] [PDF]

				L. Feng, J. Huang, and J. Chen MERIT40 facilitates BRCA1 localization and DNA damage repair Genes & Dev., March 15, 2009; 23(6): 719 - 728. [Abstract] [Full Text] [PDF]

				B. Wang and S. J. Elledge Ubc13/Rnf8 ubiquitin ligases control foci formation of the Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage PNAS, December 26, 2007; 104(52): 20759 - 20763. [Abstract] [Full Text] [PDF]

				B. Sobhian, G. Shao, D. R. Lilli, A. C. Culhane, L. A. Moreau, B. Xia, D. M. Livingston, and R. A. Greenberg RAP80 Targets BRCA1 to Specific Ubiquitin Structures at DNA Damage Sites Science, May 25, 2007; 316(5828): 1198 - 1202. [Abstract] [Full Text] [PDF]